Biomarkers Predict Brain Tumor's Response To Therapy, Harvard Medical School And Massachusetts General Hospital Study
ScienceDaily (June 24, 2009) — A report in Cancer Research highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.